For instance, Zervantonakis et al. found that fibroblasts in the tumor microenvironment of HER2 positive breast-cancer cells reduced drug sensitivity through paracrine signaling that activates mechanistic target of rapamycin (mTOR, anti-autophagic) and anti-apoptotic signals [111]. Here, MTOR is linked to breast carcinoma.